![](/img/cover-not-exists.png)
279 COMBINATION THERAPY DOES NOT IMPROVE CLINICAL AND ENDOSCOPIC REMISSION RATES WITH VEDOLIZUMAB OR USTEKINUMAB IN CROHN'S DISEASE AND ULCERATIVE COLITIS
Hu, Anne, Kotze, Paulo G., Tan, William, Jess, Alison T., Li, Pei-Shun Mimi, Kroeker, Karen I., Halloran, Brendan P., Panaccione, Remo, Ma, Christopher, Ananthakrishnan, AshwinVolume:
158
Journal:
Gastroenterology
DOI:
10.1016/S0016-5085(20)30816-7
Date:
May, 2020
File:
PDF, 268 KB
2020